Metabolic syndrome encompasses a cluster of interrelated risk factors, including glucose intolerance, obesity, dyslipidemia, and hypertension, that significantly elevate the likelihood of developing diabetes. Approximately 25% of the US population is affected by this multifaceted syndrome, imposing a substantial healthcare burden. Consequently, there is a pressing need to explore innovative . . .